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Background:  Infective  endocarditis  (IE) is  known  to be a  life-threatening  disease  and  prevention  of  its onset
is  important.  Oral  amoxicillin  (AMPC)  is generally  prescribed  to  patients  at risk for IE prior  to  undergoing
risky  procedures,  such  as  invasive  dental  treatments.  We  previously  found  that  approximately  5% of
systemically  healthy  Japanese  subjects  harbor  strains  highly  resistant  to  AMPC.  In  the  present  study,  the
prevalence  of  strains  in  patients  at  risk  for IE was investigated.
Methods and  results:  Thirty-four  Japanese  children  and  adolescents  designated  at risk  for  IE  by  their
cardiovascular  surgeons  participated.  Dental  plaque  specimens  were  obtained  at  recall  examinations  for
dental  checkups  and  placed  in  sterile  phosphate-buffered  saline,  then  diluted  and streaked  onto  selective
media  for  oral  streptococci  and also  media  containing  AMPC.  Nine  strains  with  a minimum  inhibitory
concentration  of AMPC  of  16  g/mL  or more  were  isolated  from  7 of  the subjects  (20.6%),  each  of  which
was  also  resistant  to other  antibiotics  analyzed  except  for new  quinolone  drugs.  The  16S  rRNA  sequence
of  each  strain  demonstrated  that  all were  oral  streptococcal  species.  In addition,  dental  plaque  specimens
collected  from  5 subjects  after  an  additional  interval  of 3–4  months  showed  that  2  harbored  the  same
clones  at different  time  points.
Conclusions: These  ﬁndings  suggest  a  higher  prevalence  of AMPC-resistant  strains  in  children  and  ado-
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Infective endocarditis (IE), known as an important systemic dis-
ase in the ﬁeld of dentistry, could be caused by invasive dental
rocedures such as tooth extraction in patients with underlying
eart disorders [1]. IE is a life-threatening disease, thus preven-
ion of its onset is important and oral amoxicillin (AMPC) is widely
sed for prophylaxis procedures prior to such dental treatments
2,3]. However, several case reports noting that penicillin-resistant
ral streptococci caused IE even in patients who took pre-operative
MPC have been presented [4,5].
It has been shown that the mean serum level of AMPC 4 h
fter oral administration of a 3-g dose is 8.5 ± 5.1 g/mL [6]. We
reviously attempted to isolate strains with minimum inhibitory
oncentration (MIC) values for AMPC of 16 g/mL or greater, which
nables survival in blood even when the drug is taken prior to
∗ Corresponding author at: Department of Pediatric Dentistry, Division of Oral
nfection  and Disease Control, Osaka University Graduate School of Dentistry, 1-8
amada-oka, Suita, Osaka 565-0871, Japan. Tel.: +81 6 6879 2963;
ax: +81 6 6879 2965.
E-mail  address: nakano@dent.osaka-u.ac.jp (K. Nakano).
914-5087/$ – see front matter © 2013 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jjcc.2013.05.008red  to  systemically  healthy  subjects.  Thus,  alternative  antibiotics  should
s  when  performing  prophylaxis  procedures.
anese  College  of  Cardiology.  Published  by Elsevier  Ltd.  All  rights  reserved.
treatment by patients at risk of IE [7,8]. In fact, the prevalence in
healthy Japanese children and adults of AMPC-resistant strains was
shown to be approximately 5% [7,8].
In the current guidelines for prevention of IE of the Japan Cir-
culation Society [9], oral AMPC is the ﬁrst prophylactic choice,
while intravenous ampicillin (ABPC) is another possible option.
For patients allergic to penicillin, oral clindamycin (CLDM),
azithromycin (AZM), and clarithromycin (CAM) are also recom-
mended. In addition, intravenous CLDM and cefazolin (CEZ) have
been recommended for those who  are allergic to penicillin and
unable to take medicine orally. In the present study, the preva-
lence of individuals harboring AMPC-resistant strains in the oral
cavity among patients considered to be at risk for IE was  evalu-
ated. In addition, susceptibility to other antibiotics by strains highly
resistant to AMPC was  examined.
Methods
Subjects and clinical specimensThe  protocols used in this study were approved by the Ethics
Committee of Osaka University Graduate School of Dentistry
(approval number H23-E32). The subjects were children and
vier Ltd. All rights reserved.
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dolescents who came to our clinic for periodic examinations for
ental caries and periodontal diseases from January to September
012. Among them, 34 subjects (20 males and 14 females) who  had
een designated as high risk for IE by cardiovascular surgeons were
nrolled as subjects. Their ages ranged from 4 to 19 years (median,
0 years). Prior to collecting specimens, the parents of the subjects
ere informed of the study contents and gave approval for their
articipation. Table 1 lists the number of subjects with each under-
ying heart disease, all of which are regarded as risk factors for onset
f IE in the guidelines presented by the Japan Circulation Society [9].
hose who had been taking antibiotics for 3 or more months were
xcluded. Dental plaque specimens were collected using a method
reviously described [7,8]. Brieﬂy, supra- and sub-gingival plaque
pecimens were collected from all teeth with a sterile instrument
ollowing mouth washing with water, then placed into sterile plas-
ic tubes in sterile saline on ice and transported to our laboratory,
here the following procedures were performed.
solation of AMPC-resistant oral streptococcal strains
Strains with MIC  values of 16 g/mL or more for AMPC were
solated using a method previously described [7,8]. Next, cultured
acterial cells were collected in micro-centrifuge tubes, and incu-
ated with N-acetylmuramidase SG (Seikagaku Corp., Tokyo, Japan)
nd lysozyme (Wako Pure Chemical Industries, Osaka, Japan).
enomic DNA was extracted using a Gentra Puregene Yeast/Bact.
it B (QIAGEN, Hilden, Germany), according to the manufacturer’s
nstructions. To identify the same or different clones, random
mpliﬁed polymorphic DNA (RAPD) analysis was performed using
eady-To-Go RAPD analysis beads and 6 different primers (GE
ealthcare UK Ltd., Chalfont St Giles, UK) (primer 1: 5′-GGT GCG
GA A-3′; primer 2: 5′-GTT TCG CTC C-3′; primer 3: 5′-GTA GAC
CG T-3′; primer 4: 5′-AAG AGC CCG T-3′; primer 5: 5′-AAC GCG
AA C-3′; primer 6: 5′-CCC GTC AGC A-3′), and comprised 45 cycles
f denaturing at 95 ◦C for 1 min, annealing at 36 ◦C for 1 min, and
xtension at 72 ◦C for 2 min. Amplicons were separated by elec-
rophoresis on 1.5% agarose gels.
etermination of MIC  of AMPC
The MIC  of AMPC for each strain was determined using a macro-
ilution broth method previously described by the US Clinical and
aboratory Standards Institute (CLSI, Wayne, PA, USA) [10]. Brieﬂy,
amples consisting of 950 L of Mueller-Hinton broth (Difco Lab-
ratories, Detroit, MI,  USA) supplemented with 5% deﬁbrinated
heep blood (Nippon Biotest Laboratories Inc., Tokyo, Japan) and
ontaining a 2-fold serial dilution of AMPC were placed in sterile 13-
m  × 100-mm test tubes. Test strains were cultured in brain-heart
nfusion at 37 ◦C for 18 h and washed. Next, 5 × 105 CFU was  added
o tubes containing the antimicrobial agents and incubated at 37 ◦C
or 18 h. The breakpoints of AMPC concentrations were set based
n the description by CLSI, as follows: susceptible (S: ≤0.25 g/mL),
ntermediate (I: 0.5–4 g/mL), and resistant (R: ≥ 8 g/mL).
able 1
nderlying heart diseases in 34 subjects at risk for infective endocarditis.
Underlying heart diseases Number
Ventricular septal defect 23
Tetralogy of Fallot 6
Pulmonic insufﬁciency 2
Mitral insufﬁciency 1
Post-Fontan operation for double outlet right ventricle 1
Post-Fontan operation for tricuspid and pulmonic
insufﬁciency/post pacemaker implantation
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Speciﬁcation of bacterial species
Bacterial species were identiﬁed using a method previously
described [7,8]. First, genomic DNA was  extracted using the method
described in the section above and 16S rRNA sequences of approx-
imately 1500 bp were ampliﬁed by polymerase chain reaction
(PCR) using AmpliTaq Gold polymerase (Applied Biosystems, Fos-
ter City, CA, USA) with primers 8UA (5′-AGA GTT TGA TCC TGG
CTC AG-3′) and 1540R (5′-AAG GAG GTG ATC CAG CC-3′). The
ampliﬁed fragment was  then cloned into a pGEM-T Easy vec-
tor (Promega, Fitchburg, WI,  USA), and the nucleotide sequence
was determined using a dye-terminator reaction with a DNA
sequencing system (ABI prism 310 Genetic Analyzer; Applied
Biosystems) and BigDye terminator cycle sequencing kit. The
sequences obtained were combined using GeneWorks software
(IntelliGenetics, Mountain View, CA, USA). The obtained sequences
were compared with those available in the GenBank, EMBL, and
DDBJ databases using the gapped BLASTN 2.0.5 program obtained
from the National Center for Biotechnology Information server
(http://www.ncbi.nlm.nih.gov/BLAST/). The species were deter-
mined based on identities greater than 99% in the database.
Evaluation of MIC values of various antibiotics other than AMPC
The  MICs of ABPC, CLDM, AZM, CAM, and CEZ were evaluated
using a method previously described by CLSI [10]. In addition,
those for new quinolone antibiotics, such as levoﬂoxacin (LVFX)
and tosuﬂoxacin (TFLX), were analyzed. The breakpoints of each
were determined using the CLSI guidelines [10]. As a reference, the
MICs of these antibiotics for Streptococcus sanguinis ATCC 10556,
Streptococcus oralis ATCC 10557, Streptococcus gordonii ATCC 10558,
Streptococcus mitis ATCC 49456, and Streptococcus salivarius HHT
were also measured.
Statistical analyses
Statistical analyses were performed using the computational
software package StatView 5.0 (SAS Institute Inc., Cary, NC, USA).
Fisher’s protected least-signiﬁcant difference test was  utilized to
compare the detection frequency of AMPC-resistant strains in the
present subjects at risk for IE with that for systemically healthy sub-
jects reported in our previous study [7]. Next, odds ratio (OR) and
95% conﬁdence interval (CI95) values were calculated. The results
were considered signiﬁcantly different with p-values of less than
0.05.
Results
Prevalence of subjects with AMPC-resistant strains
Table 2 summarizes subjects at risk for IE who  harbored AMPC-
resistant strains with MIC  of 16 g/mL or more. Analyses of dental
plaque specimens from 34 subjects at risk for IE revealed that 7
(20.6%) harbored streptococcal strains highly resistant to AMPC,
which was  signiﬁcantly higher than the detection rate for 253
healthy subjects (5.5%) in our previous study (p = 0.0061). The OR
value was  4.43 and the CI95 values ranged from 1.64 to 11.92.
Bacterial species identiﬁcation of the AMPC-resistant strains
Speciﬁcation of 16S rRNA alignment showed that the AMPC-
resistant streptococci belonged to S. mitis (n = 3), S. oralis (n = 1), S.
salivarius (n = 1), and S. australis (n = 1) (Table 2). In Subject C, no
alignments with strains in the database were found to have greater
than 99% identity, though a maximum similarity of 98% was  found
with S. mitis ATCC 49456.
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Table 2
Strains with high MIC  values for amoxicillin isolated from 7 subjects.
Subjects Age in
years/gender
Systemic conditions Strain
names
Strains with 99%
similarity
MIC  (g/mL)
A 4/F Ventricular septal defect HN12001-1
HN12001-2
HN12001-3
S. oralis
ATCC 35037
32
B  9/M Post-Fontan procedure for tricuspid
and pulmonic insufﬁciency/post
pacemaker  implantation
HN12003-1 S. salivarius
ATCC 7073
32
C  11/M Ventricular septal defect HN12004-1 Nonea 64
D  7/M Tetralogy of Fallot HN12011-1 S. australis
ATCC 700641
16
E  2/M Ventricular septal defect HN12020-1 S. mitis
ATCC 49456
32
F  8/F Ventricular septal defect HN12028-1 S. mitis
ATCC 49456
64
G  18/F Ventricular septal defect HN12039-1 S. mitis
ATCC 49456
64
M
B
t
4
t
3
c
r
S
A
t
t
C
w
I
o
R
t
c
s
f
F
i
It has been reported that long-term use of AMPC caused emer-
gence of resistant strains [11]. A study held in the UK in the early
1990s that focused on subjects at risk for IE found virtually noIC, minimum inhibitory concentration.
a Maximum similarity with S. mitis ATCC 49456 (98%).
acterial numbers recovered from MS  and MS-AMPC agar plates
The  numbers of bacteria recovered from the MS  agar plates for
he 34 subjects ranged from 4.3 × 104 to 2.5 × 108 CFU (median,
.3 × 106 CFU). On the other hand, those in MS-AMPC agar plates for
he 7 subjects who harbored AMPC-resistant strains ranged from
.3 × 102 to 4.2 × 105 CFU (median, 2.3 × 104 CFU). The relative per-
entage of AMPC-resistant streptococci among total streptococci
anged from 0.20% to 2.63% (Fig. 1).
usceptibility of AMPC-resistant strains to other antibiotics
The  AMPC-resistant strains were also shown to be resistant to
BPC, CLDM, CEM, CDX, AZM, CAM, and CEZ (Table 3). In contrast,
he MIC  values for the strains with LVFX and TFLX were lower than
hose designated as susceptible breakpoints.
omparison of the strains collected at different time points
Table  4 summarizes the results of recovery in subjects from
hom AMPC-resistant strains were isolated at the initial collection.
n Subjects A and B, AMPC-resistant strains were isolated from two
f three specimens after an approximately 3-month interval and
APD analyses showed that they were the same clones (Fig. 2). On
he other hand, no AMPC-resistant strains were isolated at the third
ollection after 2 or 3 months. In Subject E, two  AMPC-resistant
trains were isolated after a 3-month interval, although they dif-
ered from the initially isolated strains.
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ig. 1. Relative ratios of amoxicillin-resistant oral streptococci to total streptococci
n  each subject.Discussion
In the present study, the rate of subjects at risk for IE who  pos-
sessed AMPC-resistant strains was approximately 20%, which was
signiﬁcantly greater than that of healthy subjects (approximately
5%) reported in our previous study [7]. One possible reason for this
difference is that at-risk patients are generally treated with AMPC
more frequently than healthy individuals.Fig. 2. Comparisons of ﬁngerprinting patterns of amoxicillin-resistant strains iso-
lated from the same individuals at different times. Lane 1, NH12001-1; Lane 2,
NH12001-4; Lane 3, NH12003-1; Lane 4, NH12003-2; Lane 5, NH12020-1; Lane 6,
NH12020-2. M, molecular marker (100-bp ladder). (A) Primer 4. (B) Primer 6.
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Table  3
Antibiotic susceptibility of reference and highly amoxicillin-resistant strains.
Antibioticsa MICs (g/mL) for various antibiotics, as determined by CLSI
AMPC ABPC CLDM AZM CAM CEZ LVFX TFLX
Susceptible 0.25 ≤0.25 ≤0.25 ≤0.5 ≤0.25 ≤1 ≤2 NDb
Intermediate 0.5–4 0.5–4 0.5 1 0.5 2 4 NDb
Resistant ≥8 ≥8 ≥1 ≥2 ≥1 ≥4 ≥8 NDb
ATCC 10556 0.25 0.25 0.02 0.02 0.13 1 0.5 0.25
ATCC  10557 0.13 0.25 0.03 0.03 0.06 0.5 1 0.25
ATCC  10558 0.13 0.13 0.01 0.01 0.13 0.5 0.5 0.25
ATCC  49456 0.06 0.13 0.02 0.02 0.06 0.5 0.5 0.25
HHT  0.13 0.13 0.03 0.03 0.13 1 1 0.25
HN12001-1  32 64 0.063 16 32 32 2 0.25
HN12003-1  32 64 32 32 32 128 2 0.25
HN12004-1  64 128 0.25 32 32 >128 2 0.25
HN12011-1  16 32 1 8 32 32 1 0.25
HN12020-1  32 64 32 32 32 >128 2 0.5
HN12028-1  64 128 32 32 32 >128 4 0.5
HN12039-1  64 128 8 32 32 >128 2 0.25
MIC, minimum inhibitory concentration; AMPC, amoxicillin; ABPC, ampicillin; CLDM, clindamycin; AZM, azithromycin; CAM, clarithromycin; CEZ, cefazolin; LVFX, levoﬂox-
acin;  TFLX, tosuﬂoxacin.
 [10].
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induction of IE.
The  patients at risk for IE who  participated in this present
study came to our clinic for periodic examinations for dental
caries and periodontal diseases, although none required treatment.
Table 4
Date  of recovery trial and identities of the strains isolated from each subject.
Subjects Bacterial recovery trial
1st 2nd 3rd
A January 21 May  2 August 8
HN12001-1, 2, 3 HN12001-4 None
B January 31 May  2 July 28
HN12003-1 HN12003-2 None
C January 31 March 31 June 28
HN12004-1 None None
D March 2 August 8 –
HN12011-1 None
E May  2 August 8 –
HN12020-1 HN12020-2a MIC values for susceptible, intermediate, and resistant were designated by CLSI
b ND: not described in CLSI guidelines [10].
trains with MIC  of 24 g/mL or greater [12]. In contrast, the rate of
ubjects in Brazil at risk for IE who harbored AMPC-resistant strains
ith MIC  values of 10 g/mL or more in the oral cavity was  reported
o be 16.7% in the mid-2000s [13]. In another report, compari-
on of oral streptococci isolated from blood obtained from patients
ith IE in the USA in the periods from 1971 to 1986 and 1994 to
002 showed that susceptibility to antibiotics such as penicillin was
educed [14]. We  previously analyzed the MICs of 39 oral strepto-
occal strains isolated from blood obtained from Japanese patients
ith IE, sepsis, or bacteremia in the early 1990s and found no strains
hat were resistant to AMPC [7]. However, analysis of blood isolates
btained from IE patients from 1996 to 2004 in Taiwan showed
educed susceptibility to penicillin in approximately half of the
treptococcal strains [15]. Taken together, it is possible to spec-
late that the number of AMPC-resistant strains is increasing over
ime worldwide.
The  ratio of the number of AMPC-resistant strains to that of
ll streptococcal strains isolated from the present dental plaque
pecimens was calculated and revealed that the percentage of
treptococci with MIC  for AMPC at 16 g/mL or greater ranged from
.2% to 2.6%. It was also reported that the percentage of strains with
IC  for AMPC at 16 g/mL or greater is usually less than 5% [16].
n addition, a study held in the UK that analyzed dental plaque
pecimens from healthy subjects in the 2000s showed that the rate
f oral streptococcal strains with MICs of 8 g/mL or greater was
.4% [17]. Based on these ﬁndings, we consider that the total num-
er of AMPC-resistant strains may  be extremely low, even though
uch oral bacteria can invade the bloodstream during invasive den-
al procedures. On the other hand, the median detection rate for
MPC-resistant strains in healthy subjects in the UK who took
MPC within the past 3 months of being tested was  reported to be
0.9%, which was higher than that of subjects (2.4%) who  did not
17]. Therefore, it is important to consider that the repeated use of
MPC can elevate the ratio of the resistant strains in the entire oral
icrobiota.
The present DNA ﬁngerprinting method demonstrated that the
ame clones of AMPC-resistant strains isolated from the initial col-
ections were present after 3 months in Subjects A and B, suggesting
hat these strains were not temporally present but inhabitants.
owever, no AMPC-resistant strains were isolated at the third col-
ection, which led us to speculate that these strains were actually
nly temporary. On the other hand, the present protocol used toanalyze dental plaque specimens may  have been limited because
such an analysis only reﬂects the bacterial community in the
sampled area. Analyses using saliva specimens could solve such
problems and will be used in our subsequent studies. In Subject E,
the genotypes of the strains isolated after 3 months were different.
No strains with MIC  of AMPC of 16 g/mL or greater were isolated
after 3 months from other subjects who harbored strains with MIC
for AMPC of 16 g/mL or greater at the initial collection. These ﬁnd-
ings suggest that speciﬁc resistant species or strains are capable
of inhabiting the oral cavity, although most are only temporally
present.
The broad-range PCR and sequencing method used in the
present study speciﬁed the bacterial species of all isolated AMPC-
resistant strains, except for one strain isolated from Subject C.
For this strain, there were no other strains in the database that
matched with greater than 99% similarity and the closest was S.
mitis ATCC 49456 at 98% similarity. In general, the genus level can
be designated if the similarity is greater than 97%. Therefore, the
strain isolated from Subject C was  also likely a member of the mitis
group of streptococci which possess properties compatible with theF July 28 – –
HN12028-1
G August 31 – –
HN12039-1
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evertheless, it is possible that these individuals may  have dental
roblems that require treatment in the future. Oral AMPC is widely
sed as a prophylactic approach for IE by general dentists under the
upervision of medical doctors in the ﬁeld of cardiovascular disease
hen patients at risk undergo invasive dental treatments such as
ooth extraction [3]. When individuals harboring AMPC-resistant
treptococci in the oral cavity are subjected to such invasive den-
al treatments, it is important to consider the type of antibiotics
dministered. However, there is no information currently avail-
ble regarding such considerations. Therefore, we conducted the
resent analysis of the susceptibility of AMPC-resistant strains to
ther antibiotics listed in the guidelines for prevention of IE in
apan.
We found that strains highly resistant to AMPC were also resis-
ant to ABPC, CLDM, AZM, CAM, and CEZ. It is known that new
uinolone antibiotics are effective for Gram-positive strains resis-
ant to -lactam and macrolide antibiotics [18]. In fact, LVFX was
hown to be effective against 350 streptococcal strains including
hose resistant to penicillin [19]. In our previous study of healthy
ubjects, some strains highly resistant to AMPC were also resistant
o LVFX [8]. In the present study as well, most of the strains were
usceptible to LVFX, indicating that it may  be a useful alternative
ntibiotic agent for patients who harbor AMPC-resistant strains in
he oral cavity. However, the MIC  for LVFX against HN12028-1 iso-
ated from Subject F showed an intermediate level of susceptibility.
hus, in a search for another candidate, we also investigated TFLX,
hich is known to be effective for Streptococcus pneumoniae strains
hat are resistant to penicillin [20]. Our ﬁndings clearly showed
hat all of the present strains with high MIC  values for AMPC as
ell as the other antibiotics tested were susceptible to TFLX. There-
ore, TFLX may  be another possible drug for use with patients who
ossess strains highly resistant to AMPC.
The present results demonstrate that AMPC-resistant strains
ay be more prevalent in patients at risk for IE as compared to
ealthy individuals and that new quinolone antibiotics are a possi-
le alternative for prevention of IE in these subjects. However, we
rimarily studied children and young adults, and only 34 subjects at
isk for IE could be analyzed. Thus, a large-scale study performed by
ultiple institutions should be performed in order to conﬁrm our
esults prior to initiating discussion of possible clinical application.
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